Editorial


Cell secretome based drug substances in regenerative medicine: when regulatory affairs meet basic science

Lucian Beer, Michael Mildner, Hendrik Jan Ankersmit

Abstract

“Regenerative medicine” or “tissue regeneration” had become to an inspired term recently since it has been realized in the last decade that many organs such as the skin display morphological plasticity and possess healing capacity instead of being a post-mitotic terminally developed organ (1,2).

Download Citation